STEPHANIE BOLTON: Open Payments
NPI 1275179574 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 43 payments from 13 companies in 2025. Trend: 2023 $470 · 2024 $150 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $212 |
| Neurocrine BioSciences, Inc. | 6 | $200 |
| Teva Pharmaceuticals USA, Inc. | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $76 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| ABBVIE INC. | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 1 | $42 |
| Luye Pharma (USA) Ltd. | 1 | $29 |
Products named: FANAPT, INGREZZA, COBENFY, CAPLYTA, UZEDY, VRAYLAR, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across TN — which companies pay providers there.
